Latest Period
Q2 2026
Security Snapshot
Alamar Biosciences, Inc. - Common Stock (ALMR) Institutional Ownership
CUSIP: 010911105
13F Institutional Holders and Ownership History for Q2 2026
Institutions Reporting
85
Shares (Excl. Options)
24,374,750
Price
$27.09
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ALMR on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 24,374,750
- Total 13F value
- $660,377,538
- Portfolio coverage rank
- 0.01%
- Share change
- +24,372,719
- Value change
- +$660,322,518
- Number of holders
- 85
- Shares outstanding
- 70,761,219
- SEC-reported price per share
- $24.37
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ALMR - Alamar Biosciences, Inc. - Common Stock is tracked under CUSIP 010911105.
- 85 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Latest quarter on this page is Q2 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 85 institutions filings for Q2 2026.
Security key
010911105
Latest holder period
Q2 2026
13F holders
85
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
ALMR full holder history
Alamar Biosciences, Inc. SEC filings
Alamar Biosciences, Inc. company facts
Alamar Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 010911105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
ALMR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. | 10% | $184,649,552 | 7,066,573 | Qiming Corporate GP VI, Ltd | 30 Jun 2026 | |||
| SHERPA HEALTHCARE FUND II, L.P. | 7.2% | $110,331,653 | 4,972,134 | Daqing Cai | 16 Apr 2026 | |||
| Luo Yuling | 6.4% | $118,335,401 | 4,528,718 | Yuling Luo | 30 Jun 2026 | |||
| Sands Capital Life Sciences Pulse Fund II, L.P. | 6.1% | $93,884,248 | 4,230,926 | Sands Capital Life Sciences Pulse Fund II, L.P. | 05 Jul 2026 |
As of 30 Jun 2026, 85 institutional investors reported holding 24,374,750 shares of Alamar Biosciences, Inc. - Common Stock (ALMR). This represents 34% of the company’s total 70,761,219 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
31%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Sands Capital Alternatives, LLC | 6% | 4,230,926 | 19% | $114,615,785 | |
| SAMSARA BIOCAPITAL, LLC | 3.5% | 2,480,310 | 5.5% | $67,191,598 | |
| T. Rowe Price Investment Management, Inc. | 3.1% | 2,202,597 | 0.04% | $59,669,000 | |
| ARK Investment Management LLC | 1.9% | 1,373,959 | 0.24% | $37,220,549 | |
| BRAIDWELL LP | 1.5% | 1,083,983 | 1.1% | $29,365,099 | |
| ALLIANCEBERNSTEIN L.P. | 1.4% | 1,003,077 | 0.01% | $27,173,356 | |
| HHLR ADVISORS, LTD. | 1.4% | 956,462 | 3.1% | $25,910,556 | |
| BlackRock, Inc. | 1.3% | 911,445 | 0% | $24,691,045 | |
| MILLENNIUM MANAGEMENT LLC | 1.2% | 865,764 | 0.02% | $23,453,547 | |
| FMR LLC | 1.2% | 829,424 | 0% | $22,469,096 | |
| PURA VIDA INVESTMENTS, LLC | 1.1% | 755,909 | 55% | $20,477,575 | |
| EMERALD ADVISERS, LLC | 0.91% | 647,183 | 0.41% | $17,532,187 | |
| Artisan Partners Limited Partnership | 0.87% | 613,744 | 0.03% | $16,626,325 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0.85% | 600,000 | 0.17% | $16,254,000 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.65% | 463,385 | 0% | $12,553,100 | |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 0.65% | 462,900 | 0.07% | $12,539,961 | |
| WELLINGTON MANAGEMENT GROUP LLP | 0.65% | 457,974 | 0% | $12,406,516 | |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.6% | 422,127 | 0.4% | $11,435,420 | |
| AMERIPRISE FINANCIAL INC | 0.59% | 418,965 | 0% | $11,349,846 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.47% | 330,134 | 0% | $8,945,323 | |
| Woodline Partners LP | 0.34% | 243,320 | 0.02% | $6,591,539 | |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.28% | 200,758 | 0.01% | $5,438,534 | |
| CITADEL ADVISORS LLC | 0.25% | 180,000 | 0% | $4,876,200 | |
| LORD, ABBETT & CO. LLC | 0.25% | 177,552 | 0.01% | $4,810,000 | |
| LMR Partners LLP | 0.25% | 175,000 | 0.03% | $4,740,750 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
1
Latest
Q2 2026
Rows shown
1-1 of 1
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 24,374,750 | $660,377,538 | +$660,322,518 | $27.09 | 85 |